Payment overview · 2025
General Payments
$13.76
1 reported records · 1 companies
Healthcare provider profile · identity verified
Theodore A Bash, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · WEST BRANCH, MI · NPI 1215987235
Verified facts
What the public records show
CMS Open Payments records show Theodore A Bash, D.O. received $13.76 in general payments during 2025 across 1 reported records.
Takeda Pharmaceuticals U.S.A., Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $13.76 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $13.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EOHILIA Normalized: eohilia |
Drug | Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 442 | 99 |
| Atorvastatin Calcium | Atorvastatin Calcium | 367 | 117 |
| Omeprazole | Omeprazole | 269 | 83 |
| Levothyroxine Sodium | Levothyroxine Sodium | 268 | 81 |
| Losartan Potassium | Losartan Potassium | 240 | 75 |
| Metformin Hcl | Metformin Hcl | 225 | 71 |
| Gabapentin | Gabapentin | 221 | 57 |
| Alprazolam | Alprazolam | 199 | 34 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 198 | 65 |
| Lisinopril | Lisinopril | 197 | 59 |
| Azithromycin | Azithromycin | 178 | 96 |
| Furosemide | Furosemide | 169 | 54 |
| Amlodipine Besylate | Amlodipine Besylate | 168 | 52 |
| Eliquis | Apixaban | 166 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 153 | 51 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 148 | 24 |
| Tamsulosin Hcl | Tamsulosin Hcl | 148 | 50 |
| Fluticasone Propionate | Fluticasone Propionate | 141 | 53 |
| Montelukast Sodium | Montelukast Sodium | 138 | 41 |
| Jardiance | Empagliflozin | 121 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 116 | 38 |
| Duloxetine Hcl | Duloxetine Hcl | 114 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 113 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 108 | 36 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 98 | 30 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 97 | 39 |
| Tramadol Hcl | Tramadol Hcl | 91 | 26 |
| Carvedilol | Carvedilol | 90 | 29 |
| Prednisone | Prednisone | 88 | 45 |
| Famotidine | Famotidine | 87 | 29 |
| Simvastatin | Simvastatin | 87 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 80 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 75 | 26 |
| Potassium Chloride | Potassium Chloride | 74 | 29 |
| Fluconazole | Fluconazole | 72 | 37 |
| Sertraline Hcl | Sertraline Hcl | 70 | 20 |
| Allopurinol | Allopurinol | 69 | 25 |
| Pregabalin | Pregabalin | 67 | 15 |
| Trazodone Hcl | Trazodone Hcl | 66 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 64 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 62 | 26 |
| Ezetimibe | Ezetimibe | 61 | 21 |
| Lorazepam | Lorazepam | 60 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 60 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 58 | 16 |
| Xarelto | Rivaroxaban | 57 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | 17 |
| Glimepiride | Glimepiride | 54 | 14 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 54 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 51 | 12 |
| Clonazepam | Clonazepam | 49 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 47 | 11 |
| Ibuprofen | Ibuprofen | 47 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 47 | suppressed |
| Cefdinir | Cefdinir | 46 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 45 | 13 |
| Meloxicam | Meloxicam | 45 | 15 |
| Tradjenta | Linagliptin | 45 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 43 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 42 | 14 |
| Hydromorphone Hcl | Hydromorphone Hcl | 41 | suppressed |
| Diazepam | Diazepam | 40 | 11 |
| Fentanyl | Fentanyl | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | 12 |
| Atenolol | Atenolol | 37 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 37 | suppressed |
| Finasteride | Finasteride | 37 | 13 |
| Linzess | Linaclotide | 37 | 11 |
| Mounjaro | Tirzepatide | 37 | suppressed |
| Myrbetriq | Mirabegron | 36 | 11 |
| Bumetanide | Bumetanide | 35 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 35 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 35 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | suppressed |
| Cephalexin | Cephalexin | 33 | 25 |
| Roflumilast | Roflumilast | 33 | 11 |
| Cilostazol | Cilostazol | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 31 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Enbrel | Etanercept | 30 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 30 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Carisoprodol | Carisoprodol | 29 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 29 | 11 |
| Methotrexate | Methotrexate Sodium | 29 | suppressed |
| Amoxicillin | Amoxicillin | 28 | 15 |
| Vilazodone Hcl | Vilazodone Hcl | 28 | suppressed |
| Celecoxib | Celecoxib | 27 | suppressed |
| Januvia | Sitagliptin Phosphate | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 26 | suppressed |
| Memantine Hcl | Memantine Hcl | 26 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 26 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Novolog Flexpen | Insulin Aspart | 25 | suppressed |
| Nystatin | Nystatin | 25 | 14 |
| Baclofen | Baclofen | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Dexamethasone | Dexamethasone | 22 | 16 |
| Emgality Pen | Galcanezumab-Gnlm | 22 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 22 | 15 |
| Permethrin | Permethrin | 22 | suppressed |
| Ranolazine Er | Ranolazine | 22 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 21 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 21 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Metolazone | Metolazone | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 18 | suppressed |
| Colchicine | Colchicine | 17 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 17 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 17 | suppressed |
| Repaglinide | Repaglinide | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Primidone | Primidone | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Digoxin | Digoxin | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Ramipril | Ramipril | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Mirtazapine | Mirtazapine | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Sotalol | Sotalol Hcl | 14 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 14 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Armodafinil | Armodafinil | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Restasis Multidose | Cyclosporine | 12 | suppressed |
| Testosterone | Testosterone | 12 | suppressed |
| Bupropion Xl | Bupropion Hcl | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Paroxetine Er | Paroxetine Hcl | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $13.76 · 1 records | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error